Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bio-Star Closes Physician-Focused Vascular Device Fund

This article was originally published in Start Up

Executive Summary

Vascular-focused Bio-Star, which recently closed on a $26 million private equity fund, includes a distinquished roster of a dozen leading clinicians as investors.

You may also be interested in...

Mach Ventures: Going Small in Device Investing

Many investors worry that they've invested in products not companies: narrow technology plays that limit the size of the exit, or even it's likelihood of happening. But now comes a new venture fund, San Francisco-based Mach Ventures, that is betting that the real opportunity in devices comes precisely from technology plays that are, in fact, more truly products than full-fledged companies.

Bio-Star Fund Taps Clinical Stars

Medical practice changes so rapidly these days that many say if device companies don't have a presence in the operating room every single day, they'll rapidly fall behind the technological curve. The same is true for VCs evaluating the market potential of new technologies, which is why many partners at successful venture firms are physicians. Now, a new VC--Bio-Star Private Equity Fund, founded and funded by practicing physicians-is going a step further.

ASTM Developing Standard To Tackle Dried Blood On Steel Devices

ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts